Annex C. EURL ECVAM GIVIMP meeting 24-25 February 2015 - participating experts
|
Maria Astridou |
EFSA, Parma, Italy |
|
Camilla Bernasconi |
EURL ECVAM, Ispra, Italy |
|
Gerard Bowe |
EURL ECVAM, Ispra, Italy |
|
Ann-Charlotte Bostroem |
EURL ECVAM, Ispra, Italy |
|
Sandra Coecke |
EURL ECVAM, Ispra, Italy |
|
Thomas Cole |
EURL ECVAM, Ispra, Italy |
|
Rita Cortvrindt |
Vito, Mol, Belgium |
|
Laureano Cuevas |
Centro Nacional de Microbiologia, Majadahonda, Spain |
|
Agnieszka Dudra |
Bureau for Chemical Substances, Lodz, Poland |
|
Eugene Elmore |
University of California Irvine, Trabuco Canyon, Unites States |
|
Chantra Eskes |
SeCAM, Magliaso, Switzerland |
|
Varvara Gouliarmou |
EURL ECVAM, Ispra, Italy |
|
Andrew Gray |
United Kingdom GLP Monitoring Authority, The MHRA Medicines and Healthcare, London, United Kingdom |
|
John Harbell |
JHarbell Consulting LCC, Dallas, United States |
|
Minne Heringa |
RIVM, The National Institute for Public Health and the Environment, Centre for Safety of Substances and Products, Bilthoven, The Netherlands |
|
Delyan Ivanov |
University of Nottingham, Cancer Biology Queens Medical Centre, Nottingham, United Kingdom |
|
Rob Jaspers |
Health Care Inspectorate, The Netherlands |
|
Ingrid Langezaal |
EURL ECVAM, Ispra, Italy |
|
Marcel Leist |
University of Konstanz, Konstanz, Germany |
|
Thomas Lucotte |
ANSM, Inspectorate Department, Saint-Denis, France |
|
Marisa Meloni |
Vitroscreen SRL, Milano, Italy |
|
Maurits-Jan Prinz |
European Commission, Directorate General Internal Market, Industry, Entrepreneurship and SMEs, Brussels, Belgium |
|
Vittorio Reina, |
EURL ECVAM, Ispra, Italy |
|
Glyn N Stacey |
United Kingdom Stem Cell Bank, Advanced Therapies Division, NIBSC, United Kingdom |
|
Emanuela Testai |
Istituto Superiore di Sanita, Rome, Italy |
|
Frederique van Acker |
TNO Triskelion, Zeist, The Netherlands |
|
Iwona Wilk-Zasadna |
Novartis Vaccines, Basel, Switzerland. |
|
Maria-Chiara Zorzoli |
EURL ECVAM, Ispra, Italy |